Upadacitinib Earns FDA Approval for Ankylosing Spondylitis
Janus kinase inhibitor offers oral option for patients who have failed treatment.
FDA Approvals
source https://www.medscape.com/viewarticle/973230?src=rss
FDA Approvals
source https://www.medscape.com/viewarticle/973230?src=rss
Comments
Post a Comment